Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

"Coral bead sign" in Multicentric Reticulohistiocytosis.

Sarkar S, Fung MA, Raychaudhuri SP.

Int J Dermatol. 2019 Nov 28. doi: 10.1111/ijd.14746. [Epub ahead of print] No abstract available.

PMID:
31782143
2.

Transcriptome mining and B cell depletion support a role for B cells in psoriasis pathophysiology.

Toussi A, Merleev A, Barton VR, Le ST, Marusina A, Luxardi G, Kirma J, Xing X, Adamopoulos IE, Fung MA, Raychaudhuri SP, Shimoda M, Gudjonsson JE, Maverakis E.

J Dermatol Sci. 2019 Nov 19. pii: S0923-1811(19)30345-7. doi: 10.1016/j.jdermsci.2019.11.006. [Epub ahead of print] No abstract available.

PMID:
31780313
3.

Risk of tuberculosis with anti-tumor necrosis factor-alpha therapy in patients with psoriasis and psoriatic arthritis in Indian population.

Sarkar S, Panda S, Kim B, Raychaudhuri SK, Ghosh A, Raychaudhuri SP.

Indian J Dermatol Venereol Leprol. 2019 Nov 12. doi: 10.4103/ijdvl.IJDVL_791_18. [Epub ahead of print] Review.

PMID:
31719235
4.

Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo 18 F-FDG PET.

Raychaudhuri S, Abria C, Harmany ZT, Smith CM, Kundu-Raychaudhuri S, Raychaudhuri SP, Chaudhari AJ.

Int J Rheum Dis. 2019 Dec;22(12):2165-2169. doi: 10.1111/1756-185X.13732. Epub 2019 Oct 29.

PMID:
31659868
5.

Functional significance of MAIT cells in psoriatic arthritis.

Raychaudhuri SK, Abria C, Mitra A, Raychaudhuri SP.

Cytokine. 2020 Jan;125:154855. doi: 10.1016/j.cyto.2019.154855. Epub 2019 Sep 18.

PMID:
31541902
6.

2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells.

Le ST, Merleev AA, Luxardi G, Shimoda M, Adamopoulos IE, Tsoi LC, Wang JZ, Alexanian C, Raychaudhuri SP, Hwang ST, Gudjonsson J, Marusina AI, Maverakis E.

Front Immunol. 2019 Apr 4;10:589. doi: 10.3389/fimmu.2019.00589. eCollection 2019.

7.

IL-9 receptor: Regulatory role on FLS and pannus formation.

Raychaudhuri SK, Abria C, Maverakis EM, Raychaudhuri SP.

Cytokine. 2018 Nov;111:58-62. doi: 10.1016/j.cyto.2018.08.001. Epub 2018 Aug 14.

PMID:
30114630
8.

Meta-analysis of RNA sequencing datasets reveals an association between TRAJ23, psoriasis, and IL-17A.

Merleev AA, Marusina AI, Ma C, Elder JT, Tsoi LC, Raychaudhuri SP, Weidinger S, Wang EA, Adamopoulos IE, Luxardi G, Gudjonsson JE, Shimoda M, Maverakis E.

JCI Insight. 2018 Jul 12;3(13). pii: 120682. doi: 10.1172/jci.insight.120682.

9.

A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee.

Karlapudi V, Prasad Mungara AVV, Sengupta K, Davis BA, Raychaudhuri SP.

J Med Food. 2018 May;21(5):511-520. doi: 10.1089/jmf.2017.0065. Epub 2018 Apr 30.

PMID:
29708818
10.

Correction to: Inflammation, Atherosclerosis, and Psoriasis.

Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I.

Clin Rev Allergy Immunol. 2018 Jun;54(3):493. doi: 10.1007/s12016-018-8681-4.

PMID:
29557054
11.

Early and Delayed 99mTc-MDP SPECT/CT Findings in Rheumatoid Arthritis and Osteoarthritis.

Abdelhafez YG, Hagge RJ, Badawi RD, Raychaudhuri SP, Chaudhari AJ.

Clin Nucl Med. 2017 Nov;42(11):e480-e481. doi: 10.1097/RLU.0000000000001839.

12.

Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture.

Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, Zone JJ, Raychaudhuri SP, Maverakis E.

Indian J Dermatol. 2017 May-Jun;62(3):262-267. doi: 10.4103/0019-5154.159620.

13.

Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis.

Raychaudhuri SK, Raychaudhuri SP.

Curr Opin Rheumatol. 2017 Jul;29(4):311-316. doi: 10.1097/BOR.0000000000000399. Review.

PMID:
28394822
14.

Mechanistic rationales for targeting interleukin-17A in spondyloarthritis.

Raychaudhuri SP, Raychaudhuri SK.

Arthritis Res Ther. 2017 Mar 8;19(1):51. doi: 10.1186/s13075-017-1249-5. Review.

15.

Regulatory role of the JAK STAT kinase signalling system on the IL-23/IL-17 cytokine axis in psoriatic arthritis.

Raychaudhuri SK, Abria C, Raychaudhuri SP.

Ann Rheum Dis. 2017 Oct;76(10):e36. doi: 10.1136/annrheumdis-2016-211046. Epub 2017 Feb 8. No abstract available.

PMID:
28179265
16.

In-vivo quantitative assessment of the therapeutic response in a mouse model of collagen-induced arthritis using 18 F-fluorodeoxyglucose positron emission tomography.

Mitra A, Kundu-Raychaudhuri S, Abria C, Rona A, Chaudhari AJ, Raychaudhuri SP.

Clin Exp Immunol. 2017 May;188(2):293-298. doi: 10.1111/cei.12926. Epub 2017 Feb 24.

17.

Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.

Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri SK, Maverakis E.

J Autoimmun. 2017 Jan;76:21-37. doi: 10.1016/j.jaut.2016.10.009. Epub 2016 Nov 9. Review.

PMID:
27836567
18.

Functional Significance of Interleukin-9 and Its Receptor System in the Pathogenesis of Psoriatic Arthritis: Comment on the Article by Ciccia et al.

Raychaudhuri SK, Abria C, Raychaudhuri SP.

Arthritis Rheumatol. 2017 Feb;69(2):472-473. doi: 10.1002/art.39964. No abstract available.

19.

High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.

Chaudhari AJ, Ferrero A, Godinez F, Yang K, Shelton DK, Hunter JC, Naguwa SM, Boone JM, Raychaudhuri SP, Badawi RD.

Br J Radiol. 2016 Jul;89(1063):20160138. doi: 10.1259/bjr.20160138. Epub 2016 Apr 25.

20.

IL-23/IL-17 axis in spondyloarthritis-bench to bedside.

Raychaudhuri SP, Raychaudhuri SK.

Clin Rheumatol. 2016 Jun;35(6):1437-41. doi: 10.1007/s10067-016-3263-4. Epub 2016 Apr 13. Review.

PMID:
27075462
21.

KCa3.1(-/-) Mice Do Not Develop CIA: Regulatory Role for KCa3.1 in Autoimmune Arthritis.

Raychaudhuri SK, Wulff H, Raychaudhuri SP.

J Cell Physiol. 2016 Nov;231(11):2313-4. doi: 10.1002/jcp.25356. Epub 2016 Mar 16. No abstract available.

PMID:
26910182
22.

IL-9, a local growth factor for synovial T cells in inflammatory arthritis.

Kundu-Raychaudhuri S, Abria C, Raychaudhuri SP.

Cytokine. 2016 Mar;79:45-51. doi: 10.1016/j.cyto.2015.12.020. Epub 2016 Jan 2.

PMID:
26751012
23.

Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma.

Mitra A, Luna JI, Marusina AI, Merleev A, Kundu-Raychaudhuri S, Fiorentino D, Raychaudhuri SP, Maverakis E.

J Invest Dermatol. 2015 Nov;135(11):2873-2876. doi: 10.1038/jid.2015.252. Epub 2015 Jul 2. No abstract available.

24.

The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis.

Islam AD, Selmi C, Datta-Mitra A, Sonu R, Chen M, Gershwin ME, Raychaudhuri SP.

Autoimmun Rev. 2015 Oct;14(10):914-22. doi: 10.1016/j.autrev.2015.06.003. Epub 2015 Jun 23. Review.

PMID:
26112170
25.

Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.

Raychaudhuri SK, Saxena A, Raychaudhuri SP.

Clin Rheumatol. 2015 Jun;34(6):1019-23. doi: 10.1007/s10067-015-2961-7. Epub 2015 May 5. Review.

PMID:
25939522
26.

Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome.

Datta-Mitra A, Kundu-Raychaudhuri S, Mitra A, Raychaudhuri SP.

PLoS One. 2015 Apr 15;10(4):e0121626. doi: 10.1371/journal.pone.0121626. eCollection 2015.

27.

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.

Machado PM, Raychaudhuri SP.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):711-28. doi: 10.1016/j.berh.2014.10.004. Epub 2014 Nov 7. Review.

PMID:
25488780
28.

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer.

Datta-Mitra A, Riar NK, Raychaudhuri SP.

Indian J Dermatol. 2014 Nov;59(6):632. doi: 10.4103/0019-5154.143574. Erratum in: Indian J Dermatol. 2015 Mar-Apr;60(2):209.

29.

IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.

Mitra A, Raychaudhuri SK, Raychaudhuri SP.

Actas Dermosifiliogr. 2014 Oct;105 Suppl 1:21-33. doi: 10.1016/S0001-7310(14)70015-8. Review.

PMID:
25398489
30.

Effective strategies for the management of pyoderma gangrenosum: a comprehensive review.

Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, Garcia MS, Maverakis E.

Acta Derm Venereol. 2015 May;95(5):525-31. doi: 10.2340/00015555-2008. Review.

31.

Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.

Ogdie A, Schwartzman S, Eder L, Maharaj AB, Zisman D, Raychaudhuri SP, Reddy SM, Husni E.

J Rheumatol. 2014 Nov;41(11):2315-22. doi: 10.3899/jrheum.140882. Review.

PMID:
25362717
32.

Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.

Kundu-Raychaudhuri S, Chen YJ, Wulff H, Raychaudhuri SP.

J Autoimmun. 2014 Dec;55:63-72. doi: 10.1016/j.jaut.2014.07.003. Epub 2014 Aug 28.

33.

In vivo quantification of mouse autoimmune arthritis by PET/CT.

Kundu-Raychaudhuri S, Mitra A, Datta-Mitra A, Chaudhari AJ, Raychaudhuri SP.

Int J Rheum Dis. 2016 May;19(5):452-8. doi: 10.1111/1756-185X.12410. Epub 2014 Jun 26.

34.

The blue nails of argyria.

Raychaudhuri SP, Raychaudhuri S.

Int J Dermatol. 2014 Sep;53(9):e400-1. doi: 10.1111/ijd.12412. Epub 2014 Jun 25. No abstract available.

PMID:
24961661
35.

Severe combined immunodeficiency mouse-psoriatic human skin xenograft model: a modern tool connecting bench to bedside.

Kundu-Raychaudhuri S, Datta-Mitra A, Abria CJ, Peters J, Raychaudhuri SP.

Indian J Dermatol Venereol Leprol. 2014 May-Jun;80(3):204-13. doi: 10.4103/0378-6323.132247. Review.

36.

The classification and diagnostic criteria of ankylosing spondylitis.

Raychaudhuri SP, Deodhar A.

J Autoimmun. 2014 Feb-Mar;48-49:128-33. doi: 10.1016/j.jaut.2014.01.015. Epub 2014 Feb 16. Review.

PMID:
24534717
37.

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target.

Raychaudhuri SK, Raychaudhuri SP.

Indian J Dermatol. 2014 Jan;59(1):67-70. doi: 10.4103/0019-5154.123499.

38.

Diagnosis and classification of psoriasis.

Raychaudhuri SK, Maverakis E, Raychaudhuri SP.

Autoimmun Rev. 2014 Apr-May;13(4-5):490-5. doi: 10.1016/j.autrev.2014.01.008. Epub 2014 Jan 13. Review.

PMID:
24434359
39.

1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade.

Datta-Mitra A, Mitra A, Ray R, Raychaudhuri SP, Kundu-Raychaudhuri S.

Int Immunopharmacol. 2013 Nov;17(3):744-51. doi: 10.1016/j.intimp.2013.08.009. Epub 2013 Sep 13.

PMID:
24036370
40.

Authors' reply.

Nguyen CT, Raychaudhuri SP.

Indian J Dermatol. 2013 Jan;58(1):81. No abstract available.

41.

1α,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis.

Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R, Ray R, Kundu-Raychaudhuri S.

J Invest Dermatol. 2013 Jun;133(6):1556-64. doi: 10.1038/jid.2013.3. Epub 2013 Jan 11.

42.

Polymyositis and dermatomyositis: Disease spectrum and classification.

Raychaudhuri SP, Mitra A.

Indian J Dermatol. 2012 Sep;57(5):366-70. doi: 10.4103/0019-5154.100477.

43.

IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.

Mitra A, Raychaudhuri SK, Raychaudhuri SP.

Cytokine. 2012 Oct;60(1):38-42. doi: 10.1016/j.cyto.2012.06.316. Epub 2012 Jul 25.

PMID:
22840496
44.

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project).

Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, Walsh JA.

Ann Rheum Dis. 2013 Jun;72(6):986-91. doi: 10.1136/annrheumdis-2012-201341. Epub 2012 Jul 13.

PMID:
22798567
45.

Inflammasomes and diseases of the skin.

Mitra AD, Schrock D, Raychaudhuri SP, Raychaudhuri SK.

Indian J Dermatol Venereol Leprol. 2012 May-Jun;78(3):394-402. doi: 10.4103/0378-6323.95474. Review. No abstract available.

46.

Functional role of IL-22 in psoriatic arthritis.

Mitra A, Raychaudhuri SK, Raychaudhuri SP.

Arthritis Res Ther. 2012 Mar 14;14(2):R65. doi: 10.1186/ar3781.

47.

Role of IL-17 in psoriasis and psoriatic arthritis.

Raychaudhuri SP.

Clin Rev Allergy Immunol. 2013 Apr;44(2):183-93. doi: 10.1007/s12016-012-8307-1. Review.

PMID:
22362575
48.

A cutting edge overview: psoriatic disease.

Raychaudhuri SP.

Clin Rev Allergy Immunol. 2013 Apr;44(2):109-13. doi: 10.1007/s12016-012-8309-z. Review.

PMID:
22359072
49.

Inflammation, atherosclerosis, and psoriasis.

Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I.

Clin Rev Allergy Immunol. 2013 Apr;44(2):194-204. doi: 10.1007/s12016-012-8308-0. Review. Erratum in: Clin Rev Allergy Immunol. 2018 Mar 19;:.

PMID:
22359071
50.

Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agents.

Ratnarathorn M, Raychaudhuri SP, Naguwa S.

Indian J Dermatol. 2011 Nov;56(6):752-4. doi: 10.4103/0019-5154.91847.

Supplemental Content

Loading ...
Support Center